首页> 外文期刊>Clinical medicine: journal of the Royal College of Physicians of London >The 2016 update to NICE CG95 guideline for the investigation of new onset stable chest pain: more innovation, but at a cost?
【24h】

The 2016 update to NICE CG95 guideline for the investigation of new onset stable chest pain: more innovation, but at a cost?

机译:2016年更新到尼斯CG95对新发起胸痛调查的指南:更多的创新,但以成本为止?

获取原文
获取原文并翻译 | 示例
           

摘要

The National Institute for Health and Care Excellence (NICE) published an update on its guideline on chest pain of recent onset in 2016. The new guideline makes three key changes to the 2010 version. NICE recommend that the previously proposed pre-test probability risk score should no longer be used. They also recommend that a calcium score of zero should no longer be used to rule out coronary artery disease in patients with low pre-test probability. However, the most radical change is that NICE now recommend that all patients with new onset chest pain should be investigated with a computerised tomography coronary angiogram as a first-ine investigation. We discuss the recent trial evidence that has informed the NICE update and consider the impact of the new guidelines.
机译:国家健康和护理研究所(Nice)于2016年发布了关于最近发病近期胸痛的准则的更新。新的指南对2010年版本进行了三个关键变更。 很好建议不再使用先前提出的预测概率风险评分。 他们还建议不再使用零的钙分数来排除预测概率低患者的冠状动脉疾病。 然而,最激进的变化是现在建议所有具有新发起胸痛的患者应通过计算机层面冠状动脉血管造影作为一孔调查来调查。 我们讨论最近的试验证据,了解了良好的更新,并考虑新指南的影响。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号